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Available online 28 March 2017A strategy to reduce the deleterious effects ofmycotoxins is to use dietary supplements that containmicroorgan-
isms that bindmycotoxins anddecrease their gastrointestinal absorption.Novel strainswere isolated from aKeﬁr
culture and assessed for their mycotoxin adsorption and biotransformation ability. The most active strains were
identiﬁed using DNA sequencing, and the stability of microorganism/mycotoxin complexes was evaluated using
buffer solutions to simulate the pH conditions in the gastrointestinal tract. Our results showed that the microor-
ganism consortium of Keﬁr grains adsorbed 82 to 100% of aﬂatoxin B1 (AFB1), zearalenone (ZEA) and ochratoxin
A (OTA) when cultivated inmilk. The main strains that were capable of mycotoxin adsorption were identiﬁed as
Lactobacillus keﬁri, Kazachstania servazzii and Acetobacter syzygii. The strain L. keﬁri KFLM3 was the most active,
adsorbing 80 to 100% of the studied mycotoxins when cultivated in milk. Nonetheless, the strain K. servazzii
KFGY7 retained more mycotoxin after the desorption experiments (65, 69 and 67% for AFB1, OTA and ZEA, re-
spectively). These ﬁndings suggest that Keﬁr consumption may help to reduce gastrointestinal absorption of
these mycotoxins and consequently reduce their toxic effects. The isolated strains may be of interest for the de-
velopment of fermented dairy products for human consumption that have a new probiotic characteristic, the ad-
sorption of mycotoxins.
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Mycotoxins are ubiquitous secondarymetabolites that are produced
by ﬁlamentous fungi mainly belonging to the genera Aspergillus, Penicil-
lium and Fusarium. Mycotoxins can be found in food and animal feed
around the world (Monbaliu et al., 2009). The Food and Agriculture Or-
ganization (FAO) estimated that approximately 25% of food production
is contaminated with at least onemycotoxin (CAST, 1989). Humans are
directly exposed to mycotoxins through consumption of contaminated
plant-derived foods when agricultural commodities are colonized by
mycotoxigenic fungi or indirectly by consumption of animal-derived
products when livestock are fed mycotoxin-containing feed (Zain,
2011). A typical example is the carry-over of mycotoxins and their de-
rivatives into milk. In ruminant animals, ingested mycotoxins can be
metabolized by the rumenmicrobiota or animal organism and excreted
in milk. The carry-over into milk of aﬂatoxin M1 (AFM1), aﬂatoxicol,
cyclopiazonic acid, fumonisin B1 (FB1), ochratoxin A (OTA), T-2 toxin,, luisjap@deb.uminho.pt
of this work.deoxynivalenol and their de-epoxy-forms, zearalenone (ZEA) and its
derivative α-zearalenol, have been reported (Fink-Gremmels, 2008).
Thosemycotoxins are thermostable and are not destroyed by dairy pro-
cessing methods; they remain in pasteurized milk and in fermented
dairy products (Iha et al., 2013).
Ingestion of mycotoxins may cause acute mycotoxicosis and several
chronic adverse effects, such as mutagenic, carcinogenic, teratogenic,
estrogenic and immunosuppressive effects (Paterson and Lima, 2010).
The International Agency for Research on Cancer (IARC) classiﬁed aﬂa-
toxin B1 (AFB1) in group 1 (carcinogenic to humans), OTA and FB1 in
group 2B (possibly carcinogenic to humans) and ZEA in group 3 (not
classiﬁable as to its carcinogenicity to humans) (IARC, 2016).
Milk is the primary source of nutrition for growing infants. However,
commercial milk and milk products as well as milk of nursing women
can be contaminated with mycotoxins. Therefore, infants and young
children are more sensitive to these serious problems than adults
(Mohammadi, 2011). Studies have reported an association between
AFB1 exposure and stunted foetal, infant and child growth inWest Afri-
can countries (Gong et al., 2004). Moreover, diagnosis of nephropathic
patients from Tunisia showed that the presence of OTA was linked to
a chronic interstitial nephropathy (Zaied et al., 2011). In consideration
of the health risks and to ensure food safety, the Joint FAO/WHO Expert
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take as follows: ZEA - 0.5 μg/kg body weight per day and OTA -
112 ng/kg body weight per week, and no limits have been indicated re-
garding tolerable intake for AFB1 because of its carcinogenic effects (Bol
et al., 2016).
As a solution to this serious problem, numerous physical, chemical
and biological strategies have been reported for mycotoxin detoxiﬁca-
tion. Recently, several microorganismswere investigated for mycotoxin
degradation or adsorption, such as lactic acid bacteria (Abrunhosa et al.,
2014; Elsanhoty et al., 2013), yeasts (Petruzzi et al., 2015; Zhang et al.,
2016), and other bacteria (Harkai et al., 2016).
Keﬁr is a fermented dairy product originating from the Caucasus
Mountains. The word Keﬁr “keyif” comes from the Turkish language
and means “good feeling” owing to the refreshing nature of this bever-
age (Leite et al., 2013). It is obtained from lactic-alcoholic fermentation
of milk by gelatinous irregular grains, which range from 0.3 to 3.5 cm in
diameter. The colour of the grains varies fromwhite to light yellow, and
they resemble tiny ﬂorets of cauliﬂower (Hamet et al., 2013). Keﬁr
grains are a complex symbiotic association of lactic acid bacteria (Lacto-
bacillus keﬁri, Lactobacillus keﬁranofaciens, Lactobacillus keﬁrgranum,
Lactobacillus parakeﬁri, Lactobacillus delbrueckii, Lactobacillus acidophi-
lus, Lactobacillus brevis, Lactobacillus helveticus, Lactobacillus casei, Lacto-
bacillus paracasei, Lactobacillus fermentum, Lactobacillus plantarum, and
Lactobacillus gasseri), yeasts (Kluyveromyces marxianus, Kluyveromyces
lactis, Saccharomyces cerevisiae, Torulaspora delbrueckii, Candida keﬁr,
Pichia fermentans, Kazachstania unispora, and Kazachstania exigua) and
acetic acid bacteria that cohabitate in a protein and polysaccharide
(keﬁran) matrix (Garofalo et al., 2015). Microbial fermentation
produces several bioactive compounds, such as peptides, amino
acids, bacteriocins, ethanol, CO2, acetaldehyde, acetoin, diacetyl,
exopolysaccharides, folic acid, calcium and vitamins B1 and B12, as
well as lactic and acetic acid (Garofalo et al., 2015). Due to its high
nutritional value and content of natural probiotics, Keﬁr possesses
numerous health beneﬁts (Satir and Guzel-Seydim, 2015), including
modulating the immune system and enhancing digestive health, as
well as antimicrobial, anti-tumoral and antioxidant activities
(Ahmed et al., 2013; Vinderola et al., 2005). A few studies regarding
mycotoxin decontamination by Keﬁr have reported the ability of
Keﬁr grains to reduce 96.8% of AFG1 at a concentration of 20 μg/kg
in pistachio nuts after a 6 h contact time at 30 °C (Ansari et al.,
2015). In addition, the ability of Keﬁr grains to bind 91.9% of AFM1
(0.5 μg/L) in milk has been reported (Isakhani et al., 2014). Howev-
er, as far as we know, the effect of Keﬁr microbiota on other myco-
toxins has not previously been investigated, nor has any active
strain been isolated from it.
The objective of the current study was to investigate the microbiota
characteristics of Keﬁr fromTunisia and to isolate bacteria and/or yeasts
with biodegradation and/or adsorption properties for AFB1, OTA and
ZEA. Additionally, the main strains involved in the adsorption of myco-
toxins studied were identiﬁed by DNA sequencing, and the stability of
the microorganism/mycotoxin complexes was tested by simulating a
pH change in the gastrointestinal tract.
2. Materials and methods
2.1. Keﬁr production
Keﬁr used in this study was a traditional culture and original grain
from Monastir, Tunisia. The preparation of Keﬁr was as follow: grains
(10% w/v) were activated in commercial Ultra-high temperature cows'
milk (protein, 3.4%; fat, 1.6%; carbohydrate, 5.1%) and incubated at 25 °C
for 24 h. The grains were then retrieved by sieving from the cultured
milk and rinsed with mild sterile distilled water to remove the clotted
milk. Afterwards, the grains were re-inoculated into fresh sterile milk
and incubated under the same conditions. The milk was changed every
day during the one week incubation period. This step was repeatedtwice to obtain grains well acclimated tomilk and ready for use as starter
inocula in the following experiments.
2.2. Microbiological analysis of Keﬁr
Enumeration and isolation of microorganisms from both fermented
milk and Keﬁr grains were performed. After an incubation period of ac-
tivated grains at 25 °C for 24 h in milk, ten millilitres of Keﬁr fermented
milk was homogenized with 90 mL of a sterile sodium thiosulfate solu-
tion (0.2% w/v) for 1 min using a Stomacher. Then, ten grams of Keﬁr
grains were suspended in 90 mL of sterile saline (0.85%) and homoge-
nized with a Stomacher for 20 min. Serial decimal dilutions were pre-
pared in the same diluent, and 0.1 mL was inoculated in triplicate by
surface spreading on speciﬁc solid media. Lactic acid bacteria (LAB)
were isolated on de Man Rogosa Sharpe agar (MRS) and incubated at
30 °C under anaerobic conditions for 5 days. Yeasts were isolated on
yeast extract peptone dextrose (YPD) agar at 25 °C for 3 days. MRS
agar (Oxoid, Hampshire, UK), and YPDwas preparedwith 20 g/L of bac-
teriological peptone (Himedia, Mumbai, India), 10 g/L of yeast extract
(Himedia, Mumbai, India), 20 g/L of glucose (Fisher Chemical, Porto
Salvo, Portugal) and 20 g/L of bacteriological agar (Oxoid, Hampshire,
UK). LAB and yeasts were counted, and some strains were isolated,
streak-plate puriﬁed and examined microscopically. The results of the
viable counts were expressed as the means of colony forming units
(CFU) per gram or per mL of Keﬁr ± standard deviation. Isolated colo-
nies were grown in MRS broth supplemented with 20% glycerol and
preserved at−80 °C until further analyses.
2.3. Evaluation of mycotoxin-detoxifying properties of Keﬁr
The ability of Keﬁr cultures to biotransform or adsorb mycotoxins in
milk was ﬁrst evaluated. Stock standard solutions of AFB1 (Sigma), OTA
(Panreac) and ZEA (Sigma)were prepared in methanol at 1 mg/mL and
stored at−20 °C until use. Commercial UHT cows' milk was artiﬁcially
contaminated with 1 μg/mL of each mycotoxin (AFB1, OTA and ZEA) by
adding the appropriate amount of stock standards. Falcon tubes con-
taining 5 mL of mycotoxin-contaminated milk were prepared in tripli-
cate to study the biotransformation and adsorption properties of Keﬁr.
Keﬁr grains (10%, w/v) were added to tubes containing ﬁve millilitres
of mycotoxin-contaminated milk. The tubes were mixed and incubated
aerobically at 25 °C for 24 h. Three non-inoculated tubes containingmilk
contaminated with mycotoxins were also prepared and incubated to be
used as negative controls.
After the incubation period, for the determination of mycotoxins,
tubes intended to test biotransformation were treated differently from
those intended to test adsorption. To test biotransformation, 5 mL of
acetonitrile/methanol/acetic acid (78/20/2, v/v/v) was directly added
to tubes, and after a strong vortex mixing for 1 min, they were left to
standovernight at room temperature. Negative controlswere also treat-
ed in this way. To test adsorption, tubes were ﬁrst centrifuged at 9000
RCF for 20 min, the clear liquid fraction transferred to clean tubes and
an equal volume of the earlier organic solution was added. After being
strongly vortexed for 1 min, they were also left to stand overnight.
Thereafter, all samples were ﬁltered into clean 2-mL vials using a sy-
ringe ﬁlter (0.2 μm,Nylon) and preserved at−20 °C until HPLC analysis.
2.4. Evaluation of the mycotoxin-detoxifying properties of strains isolated
from Keﬁr
After streak-plate puriﬁcation and microscopic inspection, some of
the microorganisms isolated from Keﬁr were investigated for mycotox-
in biotransformation and adsorption properties using culturemedia and
milk. Bacteria and yeasts were propagated respectively in 10mL ofMRS
or YPD broth at 30 °C for 3 days. Optical density (O.D.) was determined
at 600 nm and adjusted to 2.0 with sterile distilled water. MRS broth,
YPD broth and milk supplemented with 1 μg/mL of each mycotoxin
Table 1
Lactic acid bacteria and yeast counts in Keﬁr culture after 24 h of fermentation inmilk. The
results are expressed as the means ± standard deviation of three independent
experiments.
Samples Viable counts on selective growth media
MRS YPD
Keﬁr grain (9.5 ± 0.15) × 1010 CFU/g (9.2 ± 0.14) × 106 CFU/g
Keﬁr milk (8.4 ± 1.03) × 107 CFU/mL (1.5 ± 0.45) × 109 CFU/mL
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ulated (1%, w/v) inMRS broth, yeasts in YPD broth and bothwere tested
in milk containing mycotoxins as described in previous section. Experi-
ments were performed in triplicate. After incubation at 25 °C for 24 h,
mycotoxins were extracted as described previously for biotransforma-
tion and adsorption experiments. Samples were ﬁltered and kept at
−20 °C until HPLC analysis.
2.5. Identiﬁcation of relevant strains
Strains isolated from Keﬁr that showed better effects for the ad-
sorption of AFB1, OTA and ZEA were grown in their appropriate
broth (MRS for lactic acid bacteria, YPD for yeast) and were identi-
ﬁed using molecular methods by STAB VIDA laboratory, Portugal.
The ampliﬁcation of 16S rDNA from the bacterial strains was per-
formed with the primers 27F (5′-AGAATTTGATCMTGGCTCAG-3′)
and 1492R (5′-TACGGYTACCTTGTTACGACTT-3′). For yeasts,
the fungal ribosomal ITS1-5.8S-ITS2 rDNA region was ampli-
ﬁed with ITS1 (5′-TCCGTAGGTGAACCTGCGG-3′) and ITS4 (5′-
TCCTCCGCTTATTGATATGC-3′); the D1/D2 domain of the
26S rDNA region was ampliﬁed using the speciﬁc primers
NL1 (5′-GCATATCAATAAGCGGAGGAAAAG-3′) and NL4 (5′-
GGTCCGTGTTTCAAGACGG-3′). The PCR products of 16S rDNA, ITS1-
5.8S-ITS2 and D1/D2 26S rDNA were sequenced, the obtained se-
quences were aligned and the percentage of homology with sequences
in the GenBank database was determined. The nucleotide sequences of
both bacteria and yeasts were submitted to the NCBI database.
2.6. Stability of the microorganism/mycotoxin complexes at different pHs
To determine the stability of the microorganism/mycotoxin com-
plexes, pellets of the Keﬁr consortium and of selected strains with
bound mycotoxins were sequentially washed with buffer solutions at
pH 7, 3 and 8 to simulate the pH conditions of the gastrointestinal
tract. Experiments were started by adding 5 mL of 0.1 M phosphate
buffer at pH 7 to pellets and by incubating under rotary agitation at 37
°C for 5 min to simulate the time spent in the mouth compartment.
Thereafter, cells were centrifuged (6500 g, 10 min, 4 °C) and the super-
natant was collected to evaluate the amount of mycotoxins released.
Then, the pellets were re-suspended in 5 mL of 0.1 M citrate/phosphate
buffer at pH 3, and the tubes were incubated under the same conditions
for 2 h to simulate the conditions of the stomach. Supernatant recovery
was performed as described previously, and pellets were re-suspended
in 5 mL of 0.1 M phosphate buffer pH 8 and incubated in the same way
for 2 h to simulate the small intestine compartment. Tubes were centri-
fuged a ﬁnal time, and the three supernatants obtained were extracted
separately as previously described in Section 2.3. The amount of re-
leased mycotoxins was quantiﬁed by HPLC, and the percentage of
each toxin bound was calculated.
2.7. Mycotoxin analysis
Quantiﬁcation of mycotoxins was performed by high performance
liquid chromatography (HPLC) with ﬂuorescence detection. The HPLC
system was equipped with a Varian Prostar 210 pump, a Varian Prostar
410 autosampler, a Jasco FP-920ﬂuorescence detector and a Jones Chro-
matography 7971 column heater that was maintained at 30 °C. The in-
strument and chromatographic data were managed by a Varian 850-
MIB data system interface and a Galaxie chromatography data system,
respectively. An analytical C18 reversed-phase YMC-Pack ODS-AQ col-
umn (250 × 4.6 mm I.D., 5 μm) connected to a pre-column with the
same stationary phase was used.
For AFB1 determination, a mixture of deionized water/acetonitrile/
methanol (3:1:1, v/v/v) was used as the mobile phase at a ﬂow rate
of 1.0 mL/min. The excitation (ex) and emission (em) wavelengths
were set at 365 and 435 nm, respectively (Soares et al., 2010). Thedetermination of OTA was performed according to Abrunhosa et al.
(2014) at ex: 333 nm and em: 460 nm. OTA was eluted isocratically
with acetonitrile/water/acetic acid (99:99:2, v/v/v) at a ﬂow rate of
1.0 mL/min. ZEA determination was performed according to
Niderkorn et al. (2007). The wavelengths used for excitation and emis-
sion were 280 and 460 nm, respectively. The mobile phase was a mix-
ture of methanol/water/acetic acid (65/35/1, v/v) pumped at a ﬂow
rate of 1.0 mL/min. Mobile phases were ﬁltered and degassed with a
0.2-μmmembraneﬁlter (GHP, Gelman). An aliquot of 50 μLwas injected
for analysis. The retention times of AFB1, OTA, and ZEA were approxi-
mately 20.3 min, 13.5 min and 19.7 min, respectively. Mycotoxins
were identiﬁed by comparing the retention times of the peak samples
with the standard curves. Standard concentration range was of 0.005–
1.0 μg/mL. The limit of detection (LOD) and the limit of quantiﬁcation
(LOQ) were calculated with a signal-to-noise ratio of 3:1 and 10:1, re-
spectively. For AFB1, LOD = 0.004 μg/mL and LOQ = 0.013 μg/mL. For
OTA, LOD = 0.005 μg/mL and LOQ = 0.017 μg/mL. For ZEA, LOD =
0.012 μg/mL and LOQ = 0.040 μg/mL. Mean recoveries were 93% ±
7.0 for AFB1, 113% ± 6.7 for OTA, and 103% ± 6.1 for ZEA.2.8. Statistical analysis
Results were expressed as mean values ± standard deviation (n =
3). The statistical analyses were performed using GraphPad Prism ver-
sion 7.00 for Windows (La Jolla, California, USA). Two-way ANOVA
and Dunnett's post-hoc test were performed to test signiﬁcant differ-
ences between microorganisms' effects and controls (p b 0.05).3. Results
3.1. Microbiological analysis of Keﬁr
As presented in Table 1, lactic acid bacteria (LAB)were the dominant
microbial population in Keﬁr. Additionally, the number of LAB was
higher in grains (9.5 × 1010 CFU/g) than in milk (8.4 × 107 CFU/mL).
Meanwhile, yeast was present in milk (1.5 × 109 CFU/mL) at consider-
ably higher amounts than in grains (9.2 × 106 CFU/g).3.2. Evaluation of the mycotoxin-detoxifying properties of Keﬁr
The biotransformation and adsorption of AFB1, OTA and ZEA by the
Keﬁr microbial consortium in milk are depicted in Table 2. Some elimi-
nation of mycotoxins was observed in the biotransformation experi-
ments. The highest percentage of elimination was obtained with AFB1
(31%), followed by OTA (12%) and ZEA (10%). No biotransformation
products were detected in the samples. Therefore, it is impossible to de-
ﬁnitively state that a chemical transformation of mycotoxins occurred.
Rather, it is more likely that the extraction process was not able to
completely extractmycotoxins from the biomass formed during the fer-
mentation process. Interestingly, in the adsorption experiments, the
Keﬁr consortium showed better results since 100% of ZEA, 94% of OTA
and 82% of AFB1 were eliminated from the liquid fraction. Thus, the
Keﬁr consortium was more efﬁcient at binding mycotoxins than at
transforming them.
Table 2
Percentage of AFB1, OTA andZEA eliminated by theKeﬁr culture during biotransformation
and adsorption experiments conducted inmilk (ﬁnal pH 4.8). The results are expressed as
themeans± standard deviation (n=3). All values are signiﬁcantly different from control
experiments (p b 0.05).
AFB1 OTA ZEA
Biotransformation (%) 31 ± 3.2 12 ± 3.3 10 ± 0.7
Adsorption (%) 82 ± 3.1 94 ± 0.8 100
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from Keﬁr
In total, twenty-two strains were isolated from Keﬁr (grains and
milk), among them, 11 Lactobacilli (LAB) and 11 yeasts. Data showed
that the biotransformation and adsorption of AFB1, OTA and ZEA were
strain and culture medium dependent (Tables 3 and 4). Nonetheless,
the binding effect was the most relevant and strong for almost all of
the isolates.
According to Table 3, the LAB binding assays for AFB1 in MRS
showed no effect (0%). However, LAB showed the ability to bind OTA
(up to 29%) and ZEA (up to 60%). Compared to the other isolates, strain
KFGM5 showed the highest binding capacity for OTA (29%), followed by
KFLM4C (16%), KFLM3 and KFGM1 (15%). Moreover, the ZEA binding
capabilities of strains KFLM3, KFGM1 and KFGM5 were the strongest
under those conditions because, respectively, 60%, 52% and 46% adsorp-
tion was observed.
The adsorption capability of eleven yeast strains in YPD medium is
also presented in Table 3. Yeasts bound small amounts of AFB1 (up to
8%) and OTA (up to 6%). Strain KFGY2 was able to remove 8% of AFB1,
whereas strains KFGY7 and KFLY6 were able to bind 6% of OTA. Greater
amounts of ZEA were eliminated from medium by yeasts (up to 44%).
Strain KFLY4 was able to bind 44% of ZEA and strain KFGY2 bound 31%
and strain KFGY1 bound 29%.
The same experiments were repeated in milk. All of the strains
changed their behaviour, and their binding ability improved as present-
ed in Table 4. The amount of mycotoxins removed in milk reached 80%Table 3
Percentage of AFB1, OTA and ZEA eliminated by the strains isolated from Keﬁr. Biotransformat
Isolates Origin AFB1 OTA
Biotransformation Adsorption Biotr
LAB in MRS medium
KFLM2 Milk 0⁎ 0⁎ 1 ±
KFLM3 Milk 0⁎ 0⁎ 8 ±
KFLM4F Milk 8 ± 1.1⁎ 0⁎ 5 ±
KFLM4C Milk 0⁎ 0⁎ 6 ±
KFGM1 Grain 0⁎ 0⁎ 2 ±
KFGM2 Grain 0⁎ 0⁎ 6 ±
KFGM3 Grain 0⁎ 0⁎ 3 ±
KFGM4 Grain 17 ± 2.3 0.2 ± 0.1⁎ 6 ±
KFGM5 Grain 0⁎ 0⁎ 44 ±
KFGM7 Grain 0⁎ 0⁎ 0⁎
KFGM8 Grain 0⁎ 0⁎ 0⁎
Yeasts in YPD medium
KFLY1 Milk 0⁎ 4 ± 1.0⁎ 0⁎
KFLY3 Milk 0⁎ 3 ± 0.8⁎ 0⁎
KFLY4 Milk 1 ± 0.9⁎ 2 ± 0.6⁎ 0⁎
KFLY5 Milk 0⁎ 5 ± 2.1⁎ 0⁎
KFLY6 Milk 0⁎ 0⁎ 4 ±
KFGY1 Grain 20 ± 3.2 7 ± 1.3⁎ 16 ±
KFGY2 Grain 5 ± 2.5 8 ± 0.9⁎ 0⁎
KFGY4 Grain 0⁎ 0⁎ 0⁎
KFGY5 Grain 0⁎ 0.5 ± 0.2⁎ 0⁎
KFGY6 Grain 0.5 ± 0.4⁎ 3 ± 1.1⁎ 0⁎
KFGY7 Grain 0⁎ 0⁎ 0⁎
The results are expressed as the means ± standard deviation (n = 3). Strains highlighted in b
⁎ Values are not signiﬁcantly different from control experiments (p b 0.05).for AFB1, 81% for OTA and 100% for ZEA, depending on the strain. The
strains KFLM3 and KFGY7 showed the highest AFB1 binding ability,
with removal percentages of 80% and 74%, respectively. The highest
amounts of OTA bound were obtained with strains KFLM3 (81%),
KFLY6 (74%) and KFGY7 (62%). We also observed that six strains,
KFLM3, KFLY1, KFLY3, KFLY5, KFGY1 and KFLY6, were able to bind the
totality of ZEA present in milk (100%) and that strain KFGY7 bound
95% of mycotoxin. These observations suggest that the binding capacity
is dependent on the particular characteristics of each strain and myco-
toxin type but also that the culture medium used to grow the strains
is the most determinant factor.
3.4. Identiﬁcation of relevant strains
Considering the results obtained in previous experiments, three
strains (KFLM3, KFGM1 andKFGY7)were selected for further character-
ization. Two strains of bacteria (KFLM3 and KFGM1) and one strain of
yeast (KFGY7) that were able to bind mycotoxins in milk were identi-
ﬁed usingmolecular methods. According to 16S rRNA gene sequencing,
the isolates KFLM3 and KFGM1 had 100% nucleotide homology with
Lactobacillus keﬁri and Acetobacter syzygii, respectively. The yeast strain
KFGY7 was identiﬁed as Kazachstania servazzii (96% homology to the
GenBank sequences). The 16S rRNA sequences of the three strains
were deposited in GenBank under the accession numbers: KX987247
for Lactobacillus keﬁri KFLM3, KX987248 for Acetobacter syzygii KFGM1
and KX987246 for Kazachstania servazzii KFGY7.
3.5. Stability of the microorganism/mycotoxin complexes at different pHs
The identiﬁed strains were assessed for microorganism/mycotoxin
complex stability by simulating the pH of the gastrointestinal tract.
The experiments involved successive treatment of pellets that had pre-
viously been bound tomycotoxins inmilk, with buffers at pH 7, 3 and 8.
The percentage of mycotoxins released was determined after each
treatment and is presented in Table 5. For the Keﬁr microbial consor-
tium, after treatment at pH 7, a considerable amount of AFB1 (20%)
and OTA (37%) were released from pellets, while for ZEA, only 14%ion and adsorption experiments were conducted in MRS and YPD.
ZEA
ansformation Adsorption Biotransformation Adsorption
0.3⁎ 8 ± 0.7⁎ 9 ± 1.3 19 ± 2.4
0.5⁎ 15 ± 2.6 56 ± 2.3 60 ± 4.0
1.6⁎ 10 ± 1.4 6 ± 0.8⁎ 12 ± 1.5
2.0⁎ 16 ± 0.4 33 ± 2.4 40 ± 2.9
0.2⁎ 15 ± 0.9 48 ± 1.0 52 ± 0.9
3.2⁎ 10 ± 1.7 12 ± 0.7 14 ± 1.7
0.5⁎ 9 ± 2.1⁎ 8 ± 2.7⁎ 16 ± 1.4
0.8⁎ 8 ± 0.4⁎ 9 ± 3.1 13 ± 1.8
3.2 29 ± 0.9 71 ± 2.8 46 ± 2.6
1 ± 0.4⁎ 10 ± 1.4 9 ± 0.5⁎
7 ± 2.7⁎ 17 ± 1.8 25 ± 2.3
0⁎ 0⁎ 1 ± 0.3⁎
0⁎ 0⁎ 8 ± 2.4⁎
0⁎ 0⁎ 44 ± 5.0
0⁎ 10 ± 0.8 12 ± 1.9
0.4⁎ 6 ± 3.8⁎ 8 ± 0.7⁎ 10 ± 1.2
2.7 5 ± 1.0⁎ 32 ± 2.4 29 ± 0.7
0⁎ 10 ± 1.6 31 ± 1.5
0⁎ 0⁎ 0⁎
0⁎ 0⁎ 0⁎
0⁎ 0⁎ 23 ± 2.1
6 ± 2.6⁎ 9 ± 1.4 18 ± 0.9
old were selected for the following experiments.
Table 4
Percentage of AFB1, OTA and ZEA eliminated by the Keﬁr strains in biotransformation and adsorption experiments conducted in milk.
Isolates Origin AFB1 OTA ZEA
Biotransformation Adsorption Biotransformation Adsorption Biotransformation Adsorption
KFLM2 Milk 5 ± 0.6⁎ 29 ± 3.4 0⁎ 7 ± 1.4⁎ 1 ± 0.4⁎ 23 ± 2.4
KFLM3 Milk 4 ± 0.3⁎ 80 ± 2.1 0⁎ 81 ± 2.7 7 ± 1.3⁎ 100
KFLM4F Milk 7 ± 0.8⁎ 24 ± 1.5 0⁎ 8 ± 1.3⁎ 0⁎ 24 ± 1.4
KFLM4C Milk 1 ± 0.6⁎ 22 ± 0.7 0⁎ 10 ± 2.8 0⁎ 20 ± 1.6
KFGM1 Grain 2 ± 0.4⁎ 65 ± 1.6 0⁎ 50 ± 0.7 0⁎ 64 ± 2.3
KFGM2 Grain 1 ± 0.5⁎ 28 ± 2.3 0⁎ 12 ± 0.3 0⁎ 19 ± 2.2
KFGM3 Grain 0⁎ 35 ± 1.9 0⁎ 11 ± 1.5 0⁎ 13 ± 2.0
KFGM4 Grain 1 ± 0.3⁎ 7 ± 1.1⁎ 4 ± 0.9⁎ 8 ± 2.3⁎ 0⁎ 0⁎
KFGM5 Grain 0⁎ 0⁎ 0⁎ 0⁎ 0⁎ 0⁎
KFGM7 Grain 0⁎ 31 ± 2.7 0⁎ 16 ± 2.1 0⁎ 25 ± 1.5
KFGM8 Grain 2 ± 0.9⁎ 20 ± 2.5 0⁎ 6 ± 1.9⁎ 0⁎ 17 ± 1.3
KFLY1 Milk 0⁎ 61 ± 3.2 0⁎ 53 ± 3.6 0⁎ 100
KFLY3 Milk 7 ± 0.8⁎ 72 ± 1.9 0⁎ 54 ± 2.7 0⁎ 100
KFLY4 Milk 6 ± 0.7⁎ 29 ± 1.8 0⁎ 8 ± 1.6⁎ 0⁎ 26 ± 2.0
KFLY5 Milk 1 ± 0.5⁎ 64 ± 2.2 0⁎ 55 ± 2.4 0⁎ 100
KFLY6 Milk 3 ± 0.9⁎ 70 ± 5.6 0⁎ 74 ± 3.5 3 ± 0.4⁎ 100
KFGY1 Grain 15 ± 1.2 71 ± 3.5 0⁎ 42 ± 2.6 0⁎ 100
KFGY2 Grain 8 ± 1.0⁎ 20 ± 3.4 0⁎ 0⁎ 0⁎ 1 ± 0.5⁎
KFGY4 Grain 0⁎ 65 ± 2.8 0⁎ 44 ± 1.8 0⁎ 82 ± 3.4
KFGY5 Grain 8 ± 1.5⁎ 7 ± 1.0⁎ 0⁎ 0⁎ 0⁎ 0⁎
KFGY6 Grain 1 ± 0.4⁎ 32 ± 4.3 0⁎ 1 ± 0.6⁎ 0⁎ 5 ± 0.8⁎
KFGY7 Grain 31 ± 2.3 74 ± 2.1 11 ± 2.0 62 ± 2.4 22 ± 2.2 95 ± 5.2
The results are expressed as the means ± standard deviation (n = 3). Strains highlighted in bold were selected for the following experiments.
⁎ Values are not signiﬁcantly different from control experiments (p b 0.05).
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bound AFB1 (6%), OTA (5%) and ZEA (0%) were released from the
Keﬁr consortium. Nonetheless, with the treatment at pH 8, further
amounts of AFB1 (14%), OTA (14%) and ZEA (51%) were released. In
total, 40, 56 and 65% of AFB1, OTA and ZEA were, respectively, released
from the Keﬁr culture biomass.
Concerning the strains isolated from Keﬁr, the results show that the
microorganism/mycotoxin complexes are more sensitive at pH 3 and
more stable at pH 7 and 8. Strain L. keﬁri KFLM3 released, after the
three treatments, a considerable amount of AFB1 (66%), OTA (74%)
and ZEA (46%). Similarly, strain A. syzygii KFGM1 released 64% of
AFB1, 65% of OTA and 55% of ZEA. Compared to bacteria, the yeast K.
servazzii KFGY7 showed the most stable microorganism/mycotoxin
complexes. As presented in Table 5, K. servazzii KFGY7 only released
35% of AFB1, 31% of OTA and 33% of ZEA. In summary, KFGY7 was the
most effective among the three tested strains.
4. Discussion
In Keﬁr grains, a high number of microorganisms involved in milk
fermentation cohabitate. Thus, the enumeration of Keﬁr strains was es-
sential to ensure their viability after the fermentation process. In the
present work, microbial analyses of both Keﬁr grains and Keﬁr
fermentedmilkwere performed. The counts of viable LAB in Keﬁr grains
were similar to those reported for Italian Keﬁr grains, which ranged be-
tween 2.4 × 107 and 1.1 × 109 CFU/g (Garofalo et al., 2015). The same
was observed with counts of viable yeasts (Garofalo et al., 2015; GulitzTable 5
Percentage of AFB1, OTA and ZEA recovered from microorganism cells after incubation with bu
Isolates AFB1 OTA
pH 7 pH 3 pH 8 Total pH 7 pH 3
Keﬁr 20 ± 1.5 6 ± 0.3 14 ± 1.5 40 ± 2.6 37 ± 2.5 5 ± 0.7
KFLM3 12 ± 0.5 37 ± 2.4 17 ± 1.3 66 ± 4.1 4 ± 0.5⁎ 45 ± 2.
KFGM1 8 ± 0.8 51 ± 2.0 5 ± 0.5 64 ± 3.1 4 ± 0.4⁎ 52 ± 3.
KFGY7 5 ± 0.4 28 ± 1.8 2 ± 0.4⁎ 35 ± 2.6 2 ± 0.7⁎ 26 ± 1.
The results are expressed as the means ± standard deviation (n = 3).
⁎ Values are not signiﬁcantly different from control experiments (p b 0.05).et al., 2011). However, the species that constitute the Keﬁr consortium
may differ in regard to the origin of the Keﬁr grains and nature of the
milk used (Garofalo et al., 2015). It has been reported that the Lactoba-
cillus spp., Lactococcus spp. and Biﬁdobacterium spp. contents were
higher in Keﬁr made with goat milk than that made with cow milk
(Satir and Guzel-Seydim, 2015).
The evaluation of the mycotoxin-detoxiﬁcation properties of the
Keﬁr consortium in milk showed that it was able to bind 82%, 94% and
100% of AFB1, OTA and ZEA, respectively. To the best of our knowledge,
there is no previous report concerning the ability of the Keﬁr consor-
tium to bind these mycotoxins. Only some references are found
concerning AFM1 (Sani et al., 2014). Because Keﬁr is a rich ecosystem
containing complex microﬂora, it was crucial to investigate the main
isolates implicated in the mycotoxin adsorption process. Thus, Keﬁr
LAB and yeast isolates were evaluated for their mycotoxin binding po-
tential in MRS and YPD medium, respectively. As depicted in Table 3,
LAB showed no effect on AFB1 binding (0%) in MRS. These data are in
disagreement with data obtained by other authors, who reported the
ability of Lactobacillus rhamnosus strains to bind 77–95% AFB1 (Turbic
et al., 2002). OTA binding by LAB isolates from Keﬁr was also assessed,
and the results showed toxin binding of 1–29%. A previous report
showed that L. plantarum could bind 12–56% of OTA (Piotrowska and
Zakowska, 2005). Similarly, Turbic et al. (2002) reported that 36–76%
of OTA was bound by L. rhamnosus strains. Moreover, all of the LAB iso-
lates from our Keﬁr demonstrated their ability to remove ZEA fromMRS
medium, with a percentage ranging between 9% and 60%. Those obser-
vations are in agreementwith those of Zhao et al. (2015), who reportedffer solutions at pH 7, 3 and 8.
ZEA
pH 8 Total pH 7 pH 3 pH 8 Total
14 ± 1.8 56 ± 4.7 14 ± 0.7 0⁎ 51 ± 2.3 65 ± 2.7
6 25 ± 2.3 74 ± 5.3 4 ± 0.6 19 ± 1.6 23 ± 1.9 46 ± 4.0
2 9 ± 0.6 65 ± 4.2 6 ± 1.0 38 ± 1.5 11 ± 1.2 55 ± 3.5
2 3 ±0.4⁎ 31 ± 2.5 5 ± 0.8 22 ± 1.0 6 ± 0.7 33 ± 2.5
6 F.B. Taheur et al. / International Journal of Food Microbiology 251 (2017) 1–7binding of ZEA in MRS by L. plantarum. Sangsila et al. (2016) also found
that 83% of ZEA was removed by Lactobacillus pentosus from a sodium
acetate solution.
In the present work, none of the yeasts isolated from Keﬁr showed a
substantial effect in binding AFB1 (0–8%) or OTA (0–6%) in YPD medi-
um. However, moderate ZEA adsorption was noted (0–44%). Recently,
Petruzzi et al. (2015) demonstrated that OTA can be bound by S.
cerevisiaeW46 in substantial amounts (43–76%). Despite the low bind-
ing percentage obtained under these conditions, we noted that themy-
cotoxin binding ability was extremely dependent on strain and
mycotoxin type. A variation in the binding ability between strains was
also reported by Peltonen et al. (2001), which considered that dissimi-
larities in the bacterial cell wall compositionwere the reason for the dif-
ferent AFB1-binding capabilities of the tested strains. The number of
binding sites available probably differs from strain to strain.
At this point, it was observed that the Keﬁr consortium adsorbed
mycotoxins in milk very well, but that the isolated strains added a lim-
ited adsorption capacity in culture medium. In addition, experiments
were carried on the isolated strains out in milk to verify whether the
composition of the medium could have inﬂuenced the binding capabil-
ity of the isolates. Remarkably, some of the Keﬁr isolates modiﬁed their
binding behaviour and showed a higher adsorption potential for the
tested mycotoxins in milk than in MRS or YPD medium. In milk, some
of the isolates were able to remove up to 80% of AFB1, up to 81% of
OTA and up to 100% of ZEA. The growth of microorganisms in milk
was probably faster than in MRS and YPD, leading to the formation of
more biomass and, consecutively, to higher binding percentages. In ad-
dition to growth, it is also possible that the nutritional composition of
milk could favour the biosynthesis of cell wall components involved in
the binding of the mycotoxins. After this characterization, some of the
best isolates were identiﬁed to species level. Based on DNA sequencing,
strains KFGM1 and KFGY7, isolated from Keﬁr grains, were identiﬁed as
A. syzygii and K. servazzii, respectively; strain KFLM3, isolated from Keﬁr
fermented milk, was identiﬁed as L. keﬁri. Their nucleotide sequences
were deposited in the National Center for Biotechnology Information
(NCBI) under the accession numbers KX987248, KX987246 and
KX987247, respectively.
Our results showed that L. keﬁri KFLM3was themost effective strain
as it bound 80%, 81% and 100% of AFB1, OTA and ZEA, respectively, in
milk. On the other hand, the bacteria A. syzygy KFGM1 bound 65%
AFB1, 50% OTA and 64% ZEA, and the yeast K. servazzii KFGY7 reduced
AFB1, OTA and ZEA in milk by 74%, 62% and 95%, respectively.
Corassin et al. (2013) also found that a mixture of lactic acid bacteria
(L. rhamnosus, L. delbrueckii subsp. bulgaricus and Biﬁdobacterium lactis)
and S. cerevisiae could completely remove AFM1 from UHT skim milk.
Our ﬁndings are also in agreement with those of El Khoury et al.
(2011), who reported that L. bulgaricus and Streptococcus thermophilus
were able to bind AFM1 in skim milk better than in PBS.
The evaluation of the stability of the microorganism/mycotoxin
complex is important for predicting the release of mycotoxins during
gastrointestinal passage and consequently for estimating the real ab-
sorption potential of mycotoxins. Thus, after the binding assays were
performed in milk, the obtained pellets (Keﬁr consortium and selected
strains) were assessed for complex stability by treatment with buffers
that had different pHs to simulate the pH of the gastrointestinal tract.
Our results showed that the binding of mycotoxins by the Keﬁr consor-
tiumwasmoderate, as 40% of AFB1, 56% of OTA and 65% of ZEAwere re-
leased into buffer after the successive treatments. Nevertheless, the
Keﬁr consortium/mycotoxin complexes were quite stable at pH 3 (no
ZEA was released, while only 5% and 6% of OTA and AFB1 were, respec-
tively, released).
The bacteria L. keﬁriKFLM3 and A. syzygii KFGM1 performed similar-
ly to the Keﬁr consortium for ZEA, but retained less AFB1 and OTA. They
released 66% and 64% of AFB1 and 74% and 65% of OTA. In this case, the
most favourable pH for the bacteria/mycotoxin complexes was pH 7,
and OTA was the least retained mycotoxin. ZEA binding by the twobacteria was most stable since only 46% and 55% of this mycotoxin
was released. Zhao et al. (2015) reported that ZEA adsorption onto L.
plantarum cell walls was also partially reversible and that a small
amount of the toxin was detected in the washing solution. Our ﬁndings
are also in accordancewith those of Haskard et al. (2001), who reported
reversible binding of aﬂatoxins to probiotic bacteria. Other authors re-
ported partially reversible AFB1 binding with L. casei, L. rhamnosus and
L. amylovorus (Hernandez-Mendoza et al., 2009; Peltonen et al., 2001).
By contrast, a stable AFM1-LAB (L. rhamnosus and L. plantarum) complex
was reported by Elsanhoty et al. (2014).
For the yeast K. servazzii KFGY7, more stable complexes were ob-
served with the mycotoxins studied than for the Keﬁr consortium, L.
keﬁri KFLM3 and A. syzygii KFGM1. Only 35% of AFB1, 31% of OTA and
33% of ZEA were released after the treatments. This means that, on av-
erage, the yeast was able to retain approx. 52% of the mycotoxins
added to milk, which was 2.6 μg. In this case, pH 3 was less favourable
for the retention of mycotoxins, while pH 7 and 8 had almost no effect
on the stability of the yeast/mycotoxin complexes since b6% of myco-
toxin was released with those treatments. Petruzzi et al. (2015) report-
ed that high amounts of OTA (80–85%) were released by S. cerevisiae
after 3 washes of 5 min with an acidic PBS solution (pH 3.5). Later,
Petruzzi et al. (2016) tested yeasts in simulated gastrointestinal condi-
tions and found they could retain 21–30% of OTA after a sequential ex-
posure of 6 h and 5 min to salivary, gastric, and intestinal simulated
juices. In our case, to simulate the passage time in the gastrointestinal
tract, we performed washings only with buffers but the total contact
time was of 4 h and 5 min. Therefore, it is expected that, in vivo, this
yeast can retain mycotoxins for a sufﬁcient time to be expelled via fae-
ces. It also should be noted that the real intake levels of the mycotoxins
via food should be less than the concentrations studied in this work. In
future experiments, this yeast will be tested in conditions that simulate
the gastrointestinal tract to conﬁrm its potential.
In summary, the mycotoxin binding process of the Keﬁr consortium
and its isolates was partially reversible, showing a moderate non-cova-
lent interaction between toxins and microorganisms. Moreover, as de-
scribed by Bevilacqua et al. (2014), the amount of mycotoxin released
into the medium was proportional to the number of treatments per-
formed. The percentage of mycotoxins released was also dependent
on the strain, buffer pH and mycotoxin type.
The binding characteristics of a strain are possibly dependent on the
exopolysaccharides produced by the microorganisms or on their cell
wall composition. LAB from Keﬁr are able to produce keﬁran (Paiva et
al., 2016). This exopolysaccharide is a hydrosoluble glucogalactan that
is mainly produced by L. keﬁranofaciens (Ahmed et al., 2013). Keﬁran
can form a transparent, ﬂexible, homogeneous and extremely thin edi-
ble ﬁlm that acts as a barrier due to itsmechanical properties (Piermaria
et al., 2009), and it is possible that this exopolysaccharide may be in-
volved in the adsorption properties of L. keﬁri KFLM3. In the case of
the yeast K. servazzii KFGY7, β-(1,3 and 1,6)-D-glucans of the cell wall
are possibly primarily responsible for the observed adsorption effects
since those glucans were also implicated in the mycotoxin-adsorbing
properties of S. cerevisiae (Piotrowska and Masek, 2015; Yiannikouris
et al., 2006).
5. Conclusions
It can be concluded from this study that Keﬁr grains and their iso-
lates (L. keﬁri KFLM3, A. syzygii KFGM1 and K. servazzii KFGY7) are
able to bind considerable amounts of mycotoxins AFB1, OTA and ZEA
in milk. However, the mycotoxin binding process of the Keﬁr grains
and of the three isolates was reversible, and different quantities of
toxin were released after exposure to successive pH treatments. Even
so, on average, the yeast K. servazzii KFGY7 was able to retain approx.
52% of the mycotoxins added to milk, L. keﬁri KFLM3 retained approx.
34% and A. syzygii KFGM1 retained 23%. The Keﬁr consortium was able
to retain approx. 42% of the mycotoxins. Thus, our ﬁndings support
7F.B. Taheur et al. / International Journal of Food Microbiology 251 (2017) 1–7that Keﬁr consumption can naturally help to avoid the deleterious ef-
fects of consumed mycotoxins. The isolated strains may be of interest
for biotechnological applications in the dairy and feed industries as a
novel source of mycotoxin-adsorbing microorganisms.Acknowledgements
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